13三体与18三体对心脏术后气道异常及肺部并发症的影响
该回顾性病例对照研究分析了1994至2014年在本机构接受心脏手术的14例13/18三体患者,并按3:1匹配非三体患者。结果显示93%的三体患者出现气道或肺部并发症,机械通气及无创正压通气时间更长、住院时间更长,但多数患者仍存活出院。建议术前与家长讨论术后气道管理。
要点
- 13/18三体患者心脏术后气道/肺部并发症发生率达93%。
- 三体患者插管时间7.5天 vs 2天,无创通气8天 vs 2天。
- 术前应告知家长术后可能需要延长呼吸支持及气道管理。
核心结论
- 多数13/18三体患者能存活心脏手术,但气道并发症发生率增加,需要更长的强化呼吸支持并导致住院时间延长。
研究设计与样本
- 回顾性病例对照队列研究,纳入1994至2014年在本机构接受心脏手术的已知13或18三体患者14例,按年龄、手术日期和心脏病变以3:1匹配非13/18三体患者。
- 比较基线临床特征和患者结局,包括术后病程与管理。
- 使用描述性统计及Wilcoxon秩和检验或Fisher精确检验确定显著差异。
主要发现
- 14例13/18三体心脏手术患者术后并发症发生率增加。
- 93%出现气道或肺部并发症,包括延长机械通气(n=8)、延长无创正压通气(n=6)、再插管(n=7)、气管炎/肺炎(n=6)和气管造口(n=2)。
- 插管时间更长(7.5 vs 2天;P < .0001),无创正压通气时间更长(8 vs 2天;P < .04),13/18三体队列住院时间更长。
- 13/18三体组院内死亡1例,对照组无死亡。
临床怎么用
- 心脏手术前与家长沟通时应包括术后气道管理的讨论。
- 对13/18三体患者心脏术后应预期更长的强化呼吸支持和住院时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence and influence of clinically significant airway and/or respiratory abnormalities in patients with trisomy 13 and 18 undergoing cardiac surgery. METHODS: We performed a retrospective, case-control cohort study of all patients with known trisomy 13 or 18 who underwent cardiac operations at our institution from 1994 to 2014. Cases were matched 3:1 by age, surgical date, and cardiac lesion with nontrisomy 13/18 patients. Baseline clinical characteristics and patient outcomes, including postoperative course and management were compared. Descriptive statistics and Wilcoxon rank-sum test or Fisher exact test as appropriate were used to determine significant differences. RESULTS: In the 14 trisomy 13/18 patients who underwent cardiac surgery, there was an increased incidence of postoperative complications. Specifically, 93% had airway or pulmonary complications, including prolonged mechanical ventilation (n = 8), prolonged noninvasive positive pressure ventilation (n = 6), re-intubation (n = 7), tracheitis/pneumonia (n = 6), and tracheostomy (n = 2). The duration of intubation was longer (7.5 vs 2 days; P < .0001) as was the duration of noninvasive positive pressure ventilation (8 vs 2 days; P < .04) with longer hospital length of stay in the trisomy 13/18 cohort. There was 1 in-hospital mortality, with none in the control group. CONCLUSIONS: Although most trisomy 13/18 patients survive cardiac surgery, these patients have an increased incidence of airway complications, requiring longer intensive respiratory support postoperatively that contributes to longer length of stay. Parental guidance before cardiac surgery should include a discussion about postoperative airway management.
引用
- Swanson SK, Schumacher KR, Ohye RG, et al. Impact of trisomy 13 and 18 on airway anomalies and pulmonary complications after cardiac surgery. J Thorac Cardiovasc Surg. 2020. PMID: 32981701. doi:10.1016/j.jtcvs.2020.08.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。